IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1194)	8/9/1997 8:07:00 PM
From: Pseudo Biologist	of 1762

You are welcome. It's a small trial and just phase I, but it does not look that impressive. Or maybe I've been spoiled by the clean data of the NHL drugs C2B8, Bexxar, etc. I know, I know, apples and oranges. I am sure there are other topoisomerase (I or II) inhibitors out there (meaning at least in clinical trials), before I hit MEDLINE again, do you know of any others and/or their results? Looking at other molecules in IDEC's pipeline, I find the Abs to B7 and CD40Ligand particularly interesting given the recent PNAS article out of U. Wisconsin/Naval Hospital/GI/Biogen on a model of organ transplantation in rhesus. Max

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next